Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Sinclair Pharma Plc" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Sinclair Pharma Plc for you to read. Along with our medical data and news we also list Sinclair Pharma Plc Clinical Trials, which are updated daily. BioPortfolio also has a large database of Sinclair Pharma Plc Companies for you to search.
Uninsured patients elibible for no-cost replacement of medicines lost in California wildfires http://bit.ly/2S5PLJM #CaliforniaWildfires #prescriptions #pharma pic.twitter.com/lS9Um7rULp
SummaryMoberg Pharma AB Moberg Pharma, formerly Moberg Derma AB, is a pharmaceutical company. The company provides commercializes proprietary, acquired and licensed products. It provides treatment of skin diseases. Moberg Pharma treats fungal infection or psoriasis, discolored and fungusdamaged nails, Fast relief of pain and itch, Waterproof liquid bandage, minor skin irritations, diaper rash, ski...
The following are some of today's top gainers in the pharma/biotech sector.
SummaryPacira Pharmaceuticals Inc Pacira discovers, develops, manufactures and commercializes drugs based on its proprietary DepoFoam drug delivery technology. Its lead product candidate, Exparel bupivacaine liposome injectable suspension is an amidetype local anesthetic indicated for infiltration into the surgical site to produce postsurgical analgesia. Its other products developed under partners...
India’s National Pharmaceutical Pricing Authority has a new chief, and pharma hopes that pricing policy outlook on the domestic market...
‘91% of employees in the pharma industry believe it is very or extremely important for pharma to deliver on its patient-focused missions’
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Genentech’s inhaled JAK1 inhibitor shows promise as a localized treatment for asthma .Numerous JAK inhibitors have been developed to treat inflammatory diseases. To avoid some common side effects … Continue reading →
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Team uncovers the underlying mechanisms of 3-D tissue formation .If you want to build an organ for transplant, you need to think in 3-D. Using stem cells, scientists … Continue reading →
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Technology Evaluated for T-cell Receptor Identification and Cloning .A team of cancer researchers developed a tracking and screening system that accurately identifies T-cell receptors from individual tumors within… … Continue reading →
(MedPage Today) -- Drugmakers ordered to provide bigger discounts under Medicare Part D, and they're fighting back
GW Pharmaceuticals plc, the world leader in the development and commercialization of cannabinoid prescription medicines, along with its US subsidiary Greenwich Biosciences, announced that results from
Pharma Technology Focus is now available on all devices. Read it for free here The top pharmaceutical companies have been...Read More... The post Pharma Technology Focus – Issue 77 appeared first on Pharmaceutical Technology.
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: New technique improves efficiency and accuracy of single cell RNA sequencing .In the era of personalized medicine, scientists are using new genetic and genomic insights to help them … Continue reading →
TAIPEI, Taiwan, Nov. 21, 2018 /PRNewswire/ — OBI Pharma, Inc., a Taiwan biopharma company (TPEx: 4174), today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for OBI-888 for the treatment of Pancreatic Cancer. OBI-888 is a first in class monoclonal antibody cancer immunotherapy targeting Globo H, a glycolipid antigen. …
The Danish company Leo Pharma and the US biotech PellePharm have joined forces to develop a topical treatment for rare forms of skin cancer. In the partnership, dermatology specialist Leo Pharma is paying PellePharm €61M. This is to fund a Phase III ... The post Leo Pharma Enters Partnership to Develop Topical Treatment for Rare Skin Cancer appeared first on Labiotech.eu.
Cambridge, UK and Indianapolis, US - 21 November 2018: Acacia Pharma Group plc ("Acacia Pharma", the "Company") (EURONEXT: ACPH) announces that data and analyses from its positive Phase 3 clinical trial of BARHEMSYS(TM) (intravenous amisulpride) as rescue treatment of established post-operative nausea & vomiting (PONV) have been published (Habib et al1) in...
Pharma companies have improved or maintained standards for effective drug recalls, product packaging and managing supply in LMICs, according to the report.
Für die Noxxon Pharma Aktie geht es heute spürbar nach oben. Am Handelssegment Euronext Growth der Pariser Börse liegt die Biotechaktie mit mehr als 7 Prozent im Plus bei 1,48 Euro, das Tageshoch i...
Mylan's Morgantown plant receives FDA warning letter http://bit.ly/2OV1B7y #pharma pic.twitter.com/E3nqpUZRdK
FDA approves first ever therapy for ultra rare primary haemophagocytic lymphohistiocytosis http://bit.ly/2PNaOEE #pharma pic.twitter.com/7DThtkgn7H
Marion Schlegel vom Anlegermagazin DER AKTIONÄR blickt in dieser Sendung auf die aktuellen Entwicklungen in der Pharma- und Biotechbranche. Heute geht es um MorphoSys, Evotec und Aurora Cannabis. W...
MHRA Chief Dr Ian Hudson to step down in 2019 http://bit.ly/2PKyI3u #pharma pic.twitter.com/Zz5TOn9PSm
SummaryRecro Pharma Inc Recro Pharma is a specialty pharmaceutical company that focuses on developing novel products for commercialization in hospital and other acute care settings and provides contract development and manufacturing CDMO services. The company is developing IV/IM Meloxicam, a proprietary, rapidonset, longacting preferential COX2 inhibitor for the treatment of acute postoperative pa...
Pfizer ask Senator Cindy Hysde-Smith to refund campaign donation after 'public hanging' comments http://bit.ly/2QYSViz #USPolitics #pharma pic.twitter.com/Z3nunuyZd6
American pharma giant Pfizer have asked Mississippi Republican Senator Cindy Hyde-Smith to return campaign donations after the candidate was filmed joking about attending a “public hanging”. Hyde-Smith said in a video that appeared on social media, “If he invited me to a public hanging, I'd be on the front row.” Pfizer made two donations towards Hyde-Smith’s campaign, coming to a t...